Table 2.
Leukocytes, neutrophils, lymphocytes, and monocytes levels in breast cancer patients before treatment and after 6 cycles of chemotherapy without Uncaria tomentosa supply (Ca group) or receiving 300 mg/day of Uncaria tomentosa (UtCa group).
| Parameters | Cycles | |||
|---|---|---|---|---|
| (cells/mm3) | 0 | 1-2 | 3-4 | 5-6 |
| Leukocytes | ||||
| Control | 6800 ± 1458 | |||
| UtCa | 6800 ± 1458 | 7890 ± 1615 | 6636 ± 2578 | 5469 ± 1626 |
| Ca | 6653 ± 1158 | 6617 ± 1504 | 4092 ± 1047∗# | 3247 ± 1117∗# |
| Neutrophils | ||||
| Control | 3510 ± 1077 | |||
| UtCa | 3496 ± 1108 | 4335 ± 1626 | 3937 ± 1992 | 4016 ± 1545 |
| Ca | 3588 ± 1081 | 2663 ± 1351* | 2028 ± 512∗# | 1083 ± 368∗# |
| Lymphocytes | ||||
| Control | 2264 ± 490,6 | |||
| UtCa | 2276 ± 503,3 | 2376 ± 708,1 | 1627 ± 578,7∗ | 1411 ± 596,6∗ |
| Ca | 2177 ± 453,3 | 2284 ± 867,9 | 1460 ± 512,5∗ | 1208 ± 395,1∗ |
| Monocytes | ||||
| Control | 487,6 ± 128,9 | |||
| UtCa | 515,3 ± 169 | 560 ± 322 | 814,9 ± 309# | 817 ± 444,6 |
| Ca | 541,6 ± 161 | 526,6 ± 154 | 654,1 ± 310∗# | 500,9 ± 226∗# |
Data expressed asmean ± standard deviation.
∗Represent difference significant between the Ca and UtCa groups, P < 0.05.
#Represent difference significant of the control group, P < 0.05 (Student's t-test).